Cargando…

“PiMa sign”: A possible correlation between dermographism and pityriasis versicolor?

Detalles Bibliográficos
Autores principales:	Martora, Fabrizio, Gallo, Lucia, Fabbrocini, Gabriella, Picone, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086803/ https://www.ncbi.nlm.nih.gov/pubmed/36048963 http://dx.doi.org/10.1111/jocd.15345

Ejemplares similares

Pityriasis Versicolor with ‘Deck Chair’ Sign
por: Saraswat, Neerja, et al.
Publicado: (2022)

Pityriasis Versicolor
Publicado: (1901)

Impact of COVID‐19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
por: Picone, Vincenzo, et al.
Publicado: (2022)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series
por: Martora, Fabrizio, et al.
Publicado: (2021)

The correct nomenclature of Zirelí sign in the propaedeutics of pityriasis versicolor (in memoriam)()()
por: Veasey, John Verrinder, et al.
Publicado: (2021)

Antifungal Treatment for Pityriasis Versicolor
por: Gupta, Aditya K., et al.
Publicado: (2015)

Dermoscopic pattern of pityriasis versicolor
por: Mathur, Mahesh, et al.
Publicado: (2019)

Note on the Treatment of Pityriasis Versicolor
por: Ritchie, James
Publicado: (1877)

A Case of New-Onset Lichen Planus after COVID-19 Vaccination
por: Picone, Vincenzo, et al.
Publicado: (2022)

A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine
por: Martora, Fabrizio, et al.
Publicado: (2022)

Dermographism
Publicado: (1893)

Epidermodysplasia verruciformis mimicking pityriasis versicolor
por: Zhang, Bin, et al.
Publicado: (2021)

“Covid arm”: Abnormal side effect after Moderna COVID‐19 vaccine
por: Picone, Vincenzo, et al.
Publicado: (2021)

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
por: Martora, Fabrizio, et al.
Publicado: (2022)

Efficacy of Azole Antifungal in Treatment of Pityriasis Versicolor
por: Cam, Van Tran, et al.
Publicado: (2019)

Relationship between helicobacter pylori infection and pityriasis versicolor:can helicobacter pylori infection be a new etiologic factor for pityriasis versicolor?
por: KUTLU, Ömer, et al.
Publicado: (2020)

Infantile hypopigmented pityriasis versicolor: two uncommon cases
por: Abdollahimajd, Fahimeh, et al.
Publicado: (2019)

Pityriasis Versicolor—A Narrative Review on the Diagnosis and Management
por: Łabędź, Nina, et al.
Publicado: (2023)

Dermographism in the Oral Cavity
por: Binmadi, Nada, et al.
Publicado: (2016)

Dermographism in COVID-19
por: Valladares, Daniel, et al.
Publicado: (2021)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Pityriasis Versicolor on Penile Shaft in a Renal Transplant Recipient
por: Ryu, Han-Won, et al.
Publicado: (2012)

A study of the prevalence and precipitating factors of pruritus in pityriasis versicolor
por: Kaushik, Ankita, et al.
Publicado: (2014)

Dermoscopy in the Evaluation of Pityriasis Versicolor: A Cross Sectional Study
por: Kaur, Ishmeet, et al.
Publicado: (2019)

Refractory dermatitis contributed by pityriasis versicolor: a case report
por: Li, Mingjia, et al.
Publicado: (2021)

Pityriasis versicolor on the scalp: An unusual distribution of a common disease
por: Wang, Lijuan, et al.
Publicado: (2023)

SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL
por: HEIDRICH, Daiane, et al.
Publicado: (2015)

Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Onset of vitiligo in a psoriasis patient on ixekizumab
por: Marasca, Claudio, et al.
Publicado: (2021)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
por: Martora, Fabrizio, et al.
Publicado: (2023)

A case of linear psoriasis in a young patient with Down syndrome and review of the literature
por: Martora, Fabrizio, et al.
Publicado: (2022)

Identification and Speciation of Malassezia in Patients Clinically Suspected of Having Pityriasis Versicolor
por: Shah, Avani, et al.
Publicado: (2013)

A case of anti- pityriasis versicolor therapy that preserves healthy mycobiome
por: Dyląg, Mariusz, et al.
Publicado: (2020)

Molecular Identification and Quantification of Malassezia Species Isolated from Pityriasis Versicolor
por: Honnavar, Prasanna, et al.
Publicado: (2020)

Pityriasis Versicolor Resistant to Antifungal Drugs in a Patient in Lomé (Togo)
por: Teclessou, Julienne, et al.
Publicado: (2022)

An Analysis of the Malassezia Species Distribution in the Skin of Patients with Pityriasis Versicolor in Chengdu, China
por: Xie, Zhen, et al.
Publicado: (2014)

Study of the Distribution of Malassezia Species in Patients with Pityriasis Versicolor in Kolar Region, Karnataka
por: Archana, Banur Raju, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_21ijfamnmfs20drenrsi27j6gh